Search / Trial NCT00001400

Outpatient Evaluation of Patients With Known or Suspected Heart Disease

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Nov 3, 1999

Trial Information

Current as of December 26, 2024

Completed

Keywords

Heart Disease Screening Follow Up

ClinConnect Summary

This protocol permits outpatient screening of patients with cardiovascular diseases who may be candidates for participation in current Cardiology Branch research protocols. No investigational treatments will be administered on this protocol.

Gender

ALL

Eligibility criteria

  • Must not be enrolled in an active Cardiology Branch research protocol.
  • The patient must be of scientific interest to the Cardiology Branch, as determined by the investigator.
  • Patient is being screened for participation in an active protocol.

About National Heart, Lung, And Blood Institute (Nhlbi)

The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials